Abstract
1

Theobromine and related methylxanthines as inhibitors of Primary Amine Oxidase
Methylxanthines are the most widely consumed drugs in the world and evidence of their health 27 benefits has been growing in recent years. Primary Amine Oxidase (PrAO) has been recognised as a 28 therapeutic target for amelioration of inflammatory, vascular and neurodegenerative diseases. 29
Previous work in our laboratories showed that caffeine inhibited Bovine PrAO with a Ki of 1.0mM 30 using benzylamine as substrate. 31
This study aimed to extend our previous work and explore the possibility that related 32 methylxanthines might influence PrAO activity. While paraxanthine, theophylline and 7-33 methylxanthine had little effect on PrAO, theobromine was a noncompetitive inhibitor with a Ki of 34 276±44µM. The specific structural elements of methylxanthines that are required for inhibition allow 35 us to suggest that their binding site on PrAO may be a target for therapeutics. The health benefits 36 associated with dietary methylxanthine consumption could involve PrAO inhibition. 37
38
Practical Applications 39
Inhibition of PrAO by methylxanthines may be significant in conferring health benefits. The design of 40
PrAO inhibitors based on the structural motifs identified in this study (N-methylation at specific 41 locations) is indicated. Existing therapeutics based on a core xanthine structure can be evaluated for 42 their effects on PrAO. Moreover, PrAO inhibition must be considered as a potential mediator of the 43 beneficial health effects of some methylxanthines. If inhibition in human tissues is comparable to, or 44 It contains a cytoplasmic domain, a transmembrane segment and an extracellular domain. In the 58 vascular endothelium the extracellular domain may be cleaved off to give rise to a circulating form 59 found in plasma. In some tissues, the membrane form acts as a Vascular Adhesion Protein (VAP-1) 60 which is involved in the migration of leukocytes through the vascular endothelium at sites of 61 inflammation (Pannecoeck et al., 2015) . This extravasion process requires the amine oxidase activity 62 catalyzed by PrAO to be intact (Noonan et al., 2013) . Both the circulating plasma form and the 63 membrane associated PrAO are active in amine oxidation and their endogenous substrates include 64 methylamine and aminoacetone (see Lyles, 1996) . These substrates are converted by PrAO to the 65 toxic aldehydes formaldehyde and methylglyoxal respectively: such aldehydes can crosslink proteins 66 in vivo giving rise to vascular damage (e.g. Unzeta et al., 2007) . Finally, it has been shown that H 2 O 2 67 generated by PrAO has a signalling role in the regulation of glucose uptake (see McDonald et al., 68 2007) . 69
Raised levels of PrAO are seen in a number of disease states including diabetes, Alzheimer's disease 70 and inflammation (Pannecoeck et al., 2015) inhibit PrAO in vivo is highly significant and points to the possibility that ingested food compounds 83 might influence PrAO in humans in a similar manner to that seen in rat tissues (Che et al., 2012) . 
Results
120
The structures of the compounds tested in this study are shown in Figure 1 . The effect of caffeine, 121 paraxanthine, theophylline, theobromine and 7-methylxanthine on PrAO at fixed concentrations of 122 500µM and 1.0mM was examined using the standard assay (Figure 2) . 123 ……FIGURE 1 HERE…….
124
Of the five methylxanthines tested only caffeine and theobromine showed substantial inhibition of 125
PrAO: surprisingly, the other compounds tested; theophylline, paraxanthine and 7-methylxanthine 126 had relatively little effect. 127
……FIGURE 2 HERE…….
128
Since caffeine is derived from xanthine we decided to test xanthine and related compounds as PrAO 129 inhibitors. Figure 3 shows that neither xanthine, its metabolites hypoxanthine and uric acid, or 130 imidazole had a significant inhibitory effect on PrAO activity at the concentrations used. 131 ……FIGURE 3 HERE…….
132
Since theobromine was the only compound showing activity comparable to that of caffeine its 133 interaction with PrAO it was examined in greater detail. The pattern of inhibition with theobromine 134 was examined using benzylamine as substrate (Figure 4a) . A noncompetitive pattern of inhibition 135 was observed and a Ki of 276±44µM was estimated from a slopes replot of this data (Fig 4b) . 136 A c t iv it y ( % m e a n S E ) *** *** ** ** ** ** *** ***
……FIGURE 4 HERE…….
